2Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes [ J]. N Engl J Med ,2004,350 : 1495-1504.
3Miller M,Cannon CP,Murphy SA,et al.PROVE-IT TIMI 22 Investigators.Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE-IT TIMI 22 trial.J Am Coll Cardiol,2008,51:724-730.
4Fruchart JC,Sacks FM,Hermans MP,et al.The Residual Risk Reduction initiative:a call to action to reduce residual vascular risk in dyslipidemic patients.A condensed position paper by the Residual Risk Reduction initiative (R3i).Diabetes Vasc Dis Res,2008,5:319-335.
5Miller M,Stone NJ,Ballantyne C,et al.Triglycerides and cardiovascular disease:a scientific statement from the American Heart Association.Circulation.2011 Apr 18.[Epub ahead of print] .
6Gitt AK,Drexel J,Ferrieres J,et al.High prevalence of dyslipidemia in 18,574 patients treated with statins in Europe and Canada:Results of the dyslipidemia international study.Eur Heart J,2009,30:303.
7Assmann G,Schulte H,Seedorf U.Cardiovascular risk assessment in the metabolic syndrome.Results from the Prospective Cardiovascular Münster (PROCAM) study.Int J Obes,2008,32:S11-16.
8Sarwar N,Danesh J,Eiriksdottir G,et al.Triglycerides and the risk of coronary heart disease:10,158 incident cases among 262,525 participants in 29 Western prospective studies.Circulation,2007,115:450-458.
9Jeppesen J,Hein HO,Suadicani P,et al.Triglyceride concentration and ischemic heart disease:an eight-year follow-up in the Copenhagen Male Study.Circulation,1998,97:1029-1036.
10Tirosh A,Rudich A,Shochat T,et al.Changes in triglyceride levels and risk for coronary heart disease in young men.Ann Intern Med,2007,147:377-385.
